Rich Fante has been named president of AstraZeneca’s U.S. business. Mr. Fante takes over from Tony Zook, whose role was expanded after recently being named president of MedImmune, AZ’s wholly-owned biologics business. Mr. Zook is chief executive officer of AstraZeneca North America and head of global marketing. Said Mr. Zook, “Rich brings strong leadership and a wealth of experience that is invaluable to our business and for improving patient health.” Previously, Mr...